HNRG vs. VRNA

Last updated Aug 1, 2026

HNRG (Hallador Energy Company) and VRNA (Verona Pharma plc) are both stocks. HNRG operates in Thermal Coal (Energy), while VRNA operates in Biotechnology (Healthcare). Their 0.08 correlation means their historical movements had little consistent relationship.

Performance

HNRG vs. VRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Hallador Energy Company (HNRG) and Verona Pharma plc (VRNA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

HNRG

• 1D: -2.67%
• 1M: -12.49%
• 6M: -23.09%
• YTD: -25.32%
• 1Y: -16.01%
• 3Y*: 13.56%
• 5Y*: 35.97%
• 10Y*: 12.23%
• ALL TIME*: 10.56%

VRNA

• 1D: —
• 1M: —
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
HNRG Hallador Energy Company	$11.20M	$11.16M	$15.32M

HNRG vs. VRNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
HNRG Hallador Energy Company	-25.32%	66.29%	29.52%	-11.51%	306.10%	67.35%	-49.34%	-39.39%	-14.71%	-13.84%
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	288.84%	-4.00%	21.74%	-40.41%	-18.71%	-12.07%

Correlation

The correlation between HNRG and VRNA is 0.04, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.04
Correlation (3Y) Balances recent behavior with more history.	0.09
Correlation (5Y) Shows whether the relationship held over a longer period.	0.11
Correlation (All Time) Calculated using the full available price history since Apr 27, 2017	0.08

Fundamentals

Market Cap HNRG : $670.19M VRNA : $9.72B
EPS HNRG : $0.51 VRNA : -$0.69
PS Ratio HNRG : 1.39 VRNA : 57.97
PB Ratio HNRG : 3.22 VRNA : 34.92
Total Revenue (TTM) HNRG : $453.49M VRNA : $167.65M
Gross Profit (TTM) HNRG : $79.39M VRNA : $159.52M
EBITDA (TTM) HNRG : $71.97M VRNA : -$40.86M

Return for Risk

HNRG vs. VRNA — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

HNRG

HNRG Risk / Return Rank: 30
HNRG Sharpe Ratio Rank: 30
HNRG Sortino Ratio Rank: 32
HNRG Omega Ratio Rank: 32
HNRG Calmar Ratio Rank: 28
HNRG Martin Ratio Rank: 26

VRNA

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

HNRG vs. VRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Hallador Energy Company (HNRG) and Verona Pharma plc (VRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	HNRG	VRNA	Difference
Sharpe ratio: Return per unit of total volatility	-0.31	—	—
Sortino ratio: Return per unit of downside risk	-0.04	—	—
Omega ratio: Gain probability vs. loss probability	1.00	—	—
Calmar ratio: Return relative to maximum drawdown	-0.46	—	—
Martin ratio: Return relative to average drawdown	-0.86	—	—

Drawdowns

Drawdown Indicators

	HNRG	VRNA	Difference
Max Drawdown Largest peak-to-trough decline	-94.89%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-42.46%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-71.13%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-71.13%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-93.19%	—	—
Current Drawdown Current decline from peak	-40.28%	—	—
Average Drawdown Average peak-to-trough decline	-45.00%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	22.55%	—	—

Volatility

Volatility by Period

	HNRG	VRNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	16.81%	—	—
Volatility (6M) Calculated over the trailing 6-month period	44.06%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	63.15%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	71.66%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	69.87%	—	—

Dividends

HNRG vs. VRNA - Dividend Comparison

Neither HNRG nor VRNA has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
HNRG Hallador Energy Company	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.72%	5.39%	3.16%	2.63%	1.76%	3.51%
VRNA Verona Pharma plc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

HNRG vs. VRNA - Profitability Comparison

The chart below illustrates the profitability comparison between Hallador Energy Company and Verona Pharma plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

HNRG - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Hallador Energy Company reported a gross profit of 59.46M and revenue of 101.81M. Therefore, the gross margin over that period was 58.4%.

VRNA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Verona Pharma plc reported a gross profit of 71.68M and revenue of 75.14M. Therefore, the gross margin over that period was 95.4%.

HNRG - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Hallador Energy Company reported an operating income of -5.65M and revenue of 101.81M, resulting in an operating margin of -5.6%.

VRNA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Verona Pharma plc reported an operating income of 9.69M and revenue of 75.14M, resulting in an operating margin of 12.9%.

HNRG - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Hallador Energy Company reported a net income of -9.32M and revenue of 101.81M, resulting in a net margin of -9.2%.

VRNA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Verona Pharma plc reported a net income of 8.69M and revenue of 75.14M, resulting in a net margin of 11.6%.

Frequently Asked Questions

Can I hold both HNRG and VRNA in my portfolio?

HNRG and VRNA have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.